Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Izobraževanje o igrifikaciji in sobi pobega v šolski knjižnici
View through CrossRef
Na Filozofski fakulteti organizirajo izobraževanje o igrifikaciji in sobi pobega v šolski knjižnici. Če vas zanimajo psihološki in pedagoški vidiki igrifikacije, bi želeli spoznati različne pristope in orodja za pripravo igrificiranih dejavnosti, ali pa nameravate takšno dejavnost v prihodnosti razviti tudi sami, se jim pridružite v soboto, 23. 3. 2024.Rok za prijavo preko spletne aplikacije KATIS je 13. 3. 2024.
Title: Izobraževanje o igrifikaciji in sobi pobega v šolski knjižnici
Description:
Na Filozofski fakulteti organizirajo izobraževanje o igrifikaciji in sobi pobega v šolski knjižnici.
Če vas zanimajo psihološki in pedagoški vidiki igrifikacije, bi želeli spoznati različne pristope in orodja za pripravo igrificiranih dejavnosti, ali pa nameravate takšno dejavnost v prihodnosti razviti tudi sami, se jim pridružite v soboto, 23.
3.
2024.
Rok za prijavo preko spletne aplikacije KATIS je 13.
3.
2024.
Related Results
Efficacy of an Extended Half-Life GlycoPEGylated rFVIII (N8-GP): Pooled Analysis of ABR (Results from Two Clinical Trials)
Efficacy of an Extended Half-Life GlycoPEGylated rFVIII (N8-GP): Pooled Analysis of ABR (Results from Two Clinical Trials)
Abstract
Introduction
The short half-life of standard factor VIII (FVIII) products means that frequent injections (3 to 4 times/week) are needed for e...
Sōbi’s Philosophy and Pedagogy
Sōbi’s Philosophy and Pedagogy
This chapter presents Sōbi's philosophy through Kubo Sadajirō's writings and advocacy, emphasizing creativity as the foundation of education and linking it to broader social well-b...
Sōbi as Organization and Movement
Sōbi as Organization and Movement
This chapter explores Sōbi as both a grassroots organization and a nationwide educational movement that promotes child-centered art education in postwar Japan. It begins with Kitag...
Biblioterapija v šolski knjižnici Dvojezične osnovne šole I Lendava
Biblioterapija v šolski knjižnici Dvojezične osnovne šole I Lendava
Avtorica obravnava biblioterapijo v šolski knjižnici Dvojezične osnovne šole I Lendava, ki jo izvaja v okviru bibliopedagoških ur. Biblioterapija odpira nove poti in priložnosti v ...
Radionice stranih jezika u Knjižnicama grada Zagreba: na primjerima Knjižnice Vladimira Nazora, Knjižnice Marina Držića, Knjižnice Silvija Strahimira Kranjčevića i Gradske knjižnice Ante Kovačića
Radionice stranih jezika u Knjižnicama grada Zagreba: na primjerima Knjižnice Vladimira Nazora, Knjižnice Marina Držića, Knjižnice Silvija Strahimira Kranjčevića i Gradske knjižnice Ante Kovačića
Cilj. Cilj je rada[1] ponuditi pregled i analizu kontinuiranih radionica stranih jezika, besplatnih za sve članove, koje su se do kraja 2018. održale u četiri područne knjižnice Kn...
Localização de Faltas em Linhas de Transmissão Baseado em Processamento Estatístico de Sinais e Aprendizado de Máquina
Localização de Faltas em Linhas de Transmissão Baseado em Processamento Estatístico de Sinais e Aprendizado de Máquina
This work presents a method for locating faults in Transmission Lines based on Independent Component Analysis (ICA) with an emphasis on the Second Order Blind Identification (SOBI)...
Safety and Efficacy of Damoctocog Alfa Pegol Prophylaxis in Patients with Severe Hemophilia A: Interim Results of a Post-Marketing, Interventional Study
Safety and Efficacy of Damoctocog Alfa Pegol Prophylaxis in Patients with Severe Hemophilia A: Interim Results of a Post-Marketing, Interventional Study
Abstract
Background
Damoctocog alfa pegol (BAY 94-9027, Jivi®) is an approved factor (F)VIII treatment indicated for use in previously treated patient...
Efficacy and Safety of Subcutaneous Prophylaxis with Concizumab in Patients with Hemophilia a or B with Inhibitors: Results from explorer4, a Phase 2, Randomized, Open-Label, Controlled Trial
Efficacy and Safety of Subcutaneous Prophylaxis with Concizumab in Patients with Hemophilia a or B with Inhibitors: Results from explorer4, a Phase 2, Randomized, Open-Label, Controlled Trial
Introduction Concizumab is an anti-tissue factor pathway inhibitor (TFPI) monoclonal antibody in clinical development for the subcutaneous prophylactic treatment of hemophilia pati...